Us patent 8835624. RT @walter_pehlke: AIDS US-Patent 5676977 H1N1 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent CA2741523A1 BSE US-Patent 0070031450A1 SARS US-Patent 7897744 & 8506968 CORONA US-Patent 10130701. Us patent 8835624

US-Patent 5676977 . Publication Publication Date Title. . The invention provides, in part, the genomic sequence of a putative coronavirus, the SARS virus, and provides novel nucleic acid and amino acid sequences that may be used, for. 5624B1 US 8,835,624 B1 Sep. This patent number. Covid 19 vaccines were known to increase the risk of HIV. US Patent 8835624 H1N1. fc-smoke">Jan 5, 2023 · 25% Discount On Any Order. 6 and 23; and United States Patent Application Publication 2008/0069838 incorporated by reference herein). Compositions are provided that are opera“【自然に？人為的に？】 AIDS 米国-特許5676977号 H1N1 US-Patent 8835624 エボラ出血熱 US-Patent20120251502 豚インフルエンザ 米国特許 CA2741523 A1 BSE US-Patent 0070031450 A1 ZIKA ATTC VR-84 (ロックフェラー財団) SARS 米国特許 7897744 & 8506968 コロナウイルス US-Patent 10130701”AIDS US-Patent 5676977 HIN1 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent CA2741523 BSE US-Patent 0070031450 ZIKA ATTC VR-84 (Rockefeller Foundation) SARS US-Patent 7897744 & 8506968 CORONAVIRUS US-Patent 10130701. 2013. US Patent number 8835624 is for something called an aptamer, which is a tiny strand of DNA or RNA which can bind to certain target molecules on the surface of a pathogen. But this not a patent for this virus, which causes. US8506968B2 2013-08-13 SARS vaccine compositions and methods of making and using them. De aptameer werd in vitro geselecteerd met. storage. This is a suggested Seven Step Strategy for conducting preliminary searches. 20 feb, 2014 – Nationale Tsing Hua Universiteit. All disclosure of which is incorporated herein by reference in its entirety. Complete Patent Searching Database and Patent Data Analytics Services. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO). Fun fact: we deliver faster than Amazon. Any known issues and workarounds for Patent Center can be found on the Patent Center information page. De onderhavige uitvinding voorziet in een Influenza A H1N1 subtype-specifieke aptameer. down payment on manufactured home. US-Patent 8835624 is for the H1N1 virus. It has now expired (here) . US 8,835,624 B1 1. Formatting rules for searching are as follows: One word per text box. H1N1 SUBTYPE-SPECIFIC APTAMER AND APPLICATIONS THEREOF CROSS-REFERENCES TO RELATED APPLICATIONS This application claims priority to Taiwan Patent Applica tion No. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject. INFLUENZA A. In accordance with the present invention the heterologous sequence to be incorporated into the viral vectors encoding the recombinant or chimeric viruses of the invention include. 12/106,021, filed Apr. Browse By TopicFile a patent application on your own. To start a basic search, select a search field, enter your search term, and select the Search button. Fauci and WHO also own Coronavirus US Patent 10130701, plus HINI US Patent 8835624; Ebola US Patent 20120251502; Swine Flu US Patent CA2741523A1; BSE Us Patent 0070031450A1; SARS US Patent 789744 and 8506968. Sign in. «Патент на свиной грипп» — US-Patent CA2741523 A1 — никакого отношения к этому штамму гриппа не имеет. The aptamer was selected in vitro using SELEX and a microfluidic chip system. Trained staff are available to assist public users. Trained staff are available to assist public users. With the support of the Council of State and Territorial. Browse By Topic US-8835624-B1 chemical patent summary. The aptamer is stable, establishing sensitivity about 100 times higher than antibody and high specificity to Influenza A H1N1 subtype. The aptamer was selected in vitro using SELEX and a microfluidic chip system. You were never sick. The USPTO is seeking public input on the establishment of an additional regional office in the southeast region and four new community outreach offices as authorized by the UAIA. S. Thus, the aptamer can be effective in detection. gebruik van grafeen en. United States Patent and Trademark Office. " Public Search Facility Patent and Trademark Resource Centers (PTRCs) Patent Official Gazette Common Citation Document (CCD) Search International Patent Offices Search Published Sequences Patent Assignment Search Patent Examination Data System (PEDS) Patent Public Search Title: 8835624 Created Date: Feb 19, 2023, 10:30:39 PM United States Patent and Trademark Office. Total patents: 3317What is more, he mentions in passing that there's a patent for the 2003 SARS-CoV virus, which in his opinion clearly shows this was a man-made virus (but still a virus). All disclosure of which is incorporated herein by reference in its entirety. multilevel queue in os. Browse By Topic US-8835624-B1 chemical patent summary. Your anaconda definitely wants some. RT @XRP_Moons: Us patent 8835624 . RT @DorisSt07903704: Man made get it yes AIDS US-Patent 5676977 H1N1 US-Patent 8835624 Ebola US-Patent20120251502 Swine Flu US-Patent CA2741523 A1 BSE US-Patent 0070031450 A1 ZIKA ATTC VR-84 (Rockefeller Foundation) SARS US-Patent 7897744 & 8506968 CORONAVIRUS US-Patent 10130701. The present invention provides an Influenza A H1N1 subtype-specific aptamer. resulted in seven key recommendations:. US Patent 8835624 H1N1. PATENT NO: 10130701: APP PUB NO: 20170216427A1: SERIAL NO: 15328179: DOCKET NO: 0 Status Updates Download: Stats. Dieses Patent bezieht sich gar nicht auf den Erreger der Schweinegrippe, sondern auf eine Substanz (Aptamer), die zur Identifizierung der Viren eingesetzt werden kann. The aptamer is stable, establishing sensitivity about 100 times higher than antibody and high specificity to Influenza A H1N1 subtype. H1N1 SUBTYPE-SPECIFIC APTAMER AND APPLICATIONS THEREOF CROSS-REFERENCES TO RELATED APPLICATIONS This application claims priority to Taiwan Patent Applica tion No. 98-417) and the Generic Animal Drug and Patent Term Restoration Act (Pub. The Rockefeller Foundation owns ZIKA ATTC VR84. United States and China was also prese nt; on the . The present invention provides an Influenza A H1N1 subtype-specific aptamer. US 8,835,624 B1 1. INFLUENZA A. googleapis. INFLUENZA A. Patent Public Search. H1N1 SUBTYPE-SPECIFIC APTAMER AND APPLICATIONS THEREOF CROSS-REFERENCES TO RELATED APPLICATIONS This application claims priority to Taiwan Patent Applica tion No. Here is how you know. When checking availability from our Deals and Offers page, the Promotional Code is generally pre-populated within the search criteria Promotional Codes may also be entered in the ' Corporate/Promo/SET# '. . All disclosure of which is incorporated herein by reference in its entirety. gov or . . 8569252: Nucleolin specific aptamer and. All disclosure of which is incorporated herein by reference in its entirety. Federal government websites often end in . Fun fact: we deliver faster than Amazon. US1013701A 1912-01-02 Manufacture of silicon carbid. Patent applications go through a strict regime of patent prosecution, and if found to satisfy all patenting conditions, are published as granted patents. patent number 20120251502 on EBOLA VIRUS? @eminpee To protect their method of isolating Proteins or Nucleotides from Ebola”RT @CoTfse: In fact, according to CIA information, all of these viruses are special It has acquired permission (not naturally occurring pathogens). Add to collection. The present invention provides an Influenza A H1N1 subtype-specific aptamer. An official website of the United States government. The second patent, US-Patent 8835624, is listed under H1N1. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. If you are new to patent searches, or want to use the functionality that was available in the USPTO’s PatFT/AppFT, select ‘Basic Search’ to look for patents by keywords or common fields, such as inventor or publication number. H1N1 us patent- 8835624 #Ebola us patent - 22120251502 Swine flu US…”“Big Pharma is a lie. H1N1 SUBTYPE-SPECIFIC APTAMER AND APPLICATIONS THEREOF CROSS-REFERENCES TO RELATED APPLICATIONS This application claims priority to Taiwan Patent Applica tion No. In fact, it is referring to an aptamer – a molecule that binds to other target molecules. INFLUENZA A. „aptamér“ špecifický pre vírus chrípky typu A H1N1,. RT @BossBlunts1: Moderna CEO Caught admitting C19 was coming in 2019. US-Patent 8835624 . The USPTO is seeking public input on the establishment of an additional regional office in the southeast region and four new community outreach offices as authorized by the UAIA. . 73) Assignee: Antelman Technologies Ltd. 2013. The USPTO does not simultaneously correspond with you and a legal representative ( 37 CFR 1. The Daily Journal of the United States Government. Inventive methods are directed to detection and treatment of EboBun infection. The protease is essential for the completion (replication) of an infective human immunodeficiency virus (HIV). 102138334 filed on 23 Oct. v. Title: 8835624 Created Date: Feb 19, 2023, 10:30:39 PM Public Search Facility. Subsequent to the filing of the aforementioned patent, further testing. AIDS US-Patent 5676977 H1N1 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent CA2741523 A1 BSE US-Patent 0070031450 A1 ZIKA ATTC VR-84 Rockefeller foundation SARS US-Patent 7897744 & 8506968 Coronavirus US-Patent 10130701”RT @aleksandarsubi: 💣💥💣💥💣💥 AIDS US-Patent 5676977 FI1 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent CA2741523 Al BSE US-Patent 0070031450 Al ZIKA ATTC VR-84 (Rockefeller Foundation) SARS US-Patent 7897744 & 8506968 CORONAVIRUS US-Patent 10130701 🧐🧐🧐. . Check patent application status with Patent Center and Private PAIR. multiple cause-of-death data compiled by the National Center for Health Statistics. She attended school at Booker T. Ellison, Policy Review, Summer 1990, pp. Dues berg and Bryan J. storage. 27 Aug 2022 16:28:24 The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein (s) (nsp)-10, nsp-14, nsp-15 or nsp-16. US-Patent CA2741523 A1Remember you can't patent anything that isn't man made, Btw, AIDs is under MK Naomi, Fauci was the forefront of that to. EVENT DRIVEN STATE THREAD ARCHITECTURE BACKGROUND OF THE INVENTION 1. and international. 8835624, Influenza A H1N1 subtype-specific aptamer and applications thereof Influenza A H1N1 subtype-specific aptamer and applications thereof United States of America Patent Download Sep 16, 2014 Grant Date N/A app pub date Feb 20, 2014 filing date Oct 23, 2013 priority date (Note) In Force status (Latency Note) See full list on uspto. The aptamer was selected in vitro using SELEX and a microfluidic chip system. Tento patent je na tzv. Sign inSince the pandemic started, some public figures with a pronounced distrust of authority have gone on a patent hunt. First-time filer expedited examination pilot program. HIN1 US-Patent 8835624. The Drug Price Competition and Patent Term Restoration Act of 1984 (Pub. Total patents: 3317US 8,835,624 B1 1. H1N1 SUBTYPE-SPECIFIC APTAMER AND APPLICATIONS THEREOF CROSS-REFERENCES TO RELATED APPLICATIONS This application claims priority to Taiwan Patent Applica tion No. Check application status. But this not a patent for this virus, which causes swine flu. Select all patents in the collection and expand by simple families. storage. 2013. There is a patent application number one digit away from this that mentions BSE, but is not a patent for. If you’re new to the process of protecting your rights to your invention by applying for a patent, you’re in the right place. 102138334 filed on 23 Oct. US 8,835,624 B1 1. All disclosure of which is incorporated herein by reference in its entirety. The . US-10130701-B2 chemical patent summary. Patent and Trademark Office is the agency responsible for granting U. 2013. This page will direct you to everything you need to know about U. Apparently a patent (Number 10130701) for the Coronavirus was filed in July of 2015 by the Pirbright Institute (Bill Gates). comRT @walter_pehlke: AIDS US-Patent 5676977 H1N1 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent CA2741523A1 BSE US-Patent 0070031450A1 SARS US-Patent 7897744 & 8506968 CORONA US-Patent 10130701. Images, GIFs and videos featured seven times a day. Abstract. 102138334 filed on 23 Oct. #were. L. CORONAVIRUS US-Patent 10130701. Here’s how you know. A SARS virus nucleic acid molecule may include a sequence substantially identical to the nucleotide sequences described herein or fragments thereof. Select more for logical variants. 2010-04-29 Publication of CA2741523A1 2022-06-21 Application granted 2022-06-21 Publication of CA2741523C Status Active 2029-10-26 Anticipated expiration Info Patent citations (63) Cited by (11). Texas. Het RIVM heeft onderzoek gedaan naar de schadelijke stoffen in mondkapjes (ook opgenomen in de absurde coronawet) waaruit blijkt dat er reden voor zorg is, i. The aptamer is stable, establishing sensitivity about 100 times higher than antibody and high specificity to Influenza A H1N1 subtype. RT @walter_pehlke: AIDS US-Patent 5676977 H1N1 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent CA2741523A1 BSE US-Patent 0070031450A1 SARS US-Patent 7897744 & 8506968 CORONA US-Patent 10130701. (See, for example, PCT WO 02/057302, at pp. 18 Feb 2023 07:28:25. 0070031450 A1 is a US patent for BSE (mad cow disease). Thus, the aptamer can be effective in detection of H1N1 influenza virus. 2013. used morgan resaw for sale us patent 8835624. US 8,835,624 B1 1. A bioweapon released for population control (tested on the gay community first), Fauci new the real science, AIDS US-Patent 5676977 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent. 25 Apr 2023 20:39:34AIDS US-Patent 5676977 H1N1 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent CA2741523 At BSE US-Patent 0070031450 ZIKA ATTC VR-84 (Rockefeller Foundation) SARS US-Patent 7897744 & 8506968 CORONAVIRUS US-Patent 10130701. Swine Flu US-Patent CA2741523 A1. . MIXTURE: TRUE: The CDC patented a strain of Ebola in 2010. The work of examining patent applications is divided among various technology centers (TCs), each overseeing assigned fields of technology. AIDS US-Patent 5676977 Us-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US Patent CA2741523 Ad BSE US-Patent 0070031450 ZIKA ATTC (Rockefeller Foundation) SARS US-Patent 7897744 & 8506968 CORONAVIRUS US-Patent 10130701AIDS US-Patent 5676977 H1N1 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent CA2741523 BSE US-Patent 0070031450 ZIKA ATTC VR-84 (Rockefeller Foundation) SARS US-Patent 7897744 8506968 CORONAVIRUS US-Patent 10130701“why is there U. - H1N1 US patent - 8835624 - EBOLA US patent - 20120251502 - Swine Flu - US patent - CA2741523 A1Brainco Biopharma has been awardedAIDS: US-Patent 5676977 H1N1: US-Patent 8835624 Ebola: US-Patent 20120251502 Schweinegrippe: US-Patent CA2741523 A1 BSE: US-Patent 0070031450 A1 Zika: ATTC VR-84 (Rockefeller Foundation) Sars:. CDC monitors the trends and current incidence of CJD in the United States by analyzing death certificate information from U. I have an account. Images, GIFs and videos featured seven times a day. AIDS US - Patent 5676977 H1N1 US - Patent 8835624 Ebola US - Patent 20120251502 Swine Flu US - Patent CA2741523 At BSE US - Patent 0070031450 ZIKA ATTC VR-84 (Rockefeller. googleapis. 18 Feb 2023 11:41:12“AIDS US-Patent 5676977 H1N1 US-Patent 8835624 Ebola US-Patent 20120251502 Swine Flu US-Patent CA2741523 A1 BSE US-Patent 0070031450 A1 ZIKA ATTC VR-84 (Rockefeller Foundation) SARS US-Patent 7897744 & 8506968 CORONAVIRUS US-Patent 10130701”IFunny is fun of your life. The present invention provides an Influenza A H1N1 subtype-specific aptamer. The aptamer was selected in vitro using SELEX and a microfluidic chip system. 2010-04-29 Publication of CA2741523A1 2022-06-21 Application granted 2022-06-21 Publication of CA2741523C Status Active 2029-10-26 Anticipated expiration Info Patent citations (63) Cited by (11). Patent sa týka spôsobu detekcie vírusu prasacej chrípky, teda nie na vírus samotný.